Biospecimen Resource for Pancreas Research, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease


Rochester, Minn., Jacksonville, Fla., Phoenix/Scottsdale, Ariz.

Trial status:

Open for Enrollment

Why is this study being done?

OBJECTIVES: Primary - To collect clinical data and family histories and blood and/or tissue samples from patients diagnosed with pancreatic diseases, including pancreatic cancer, for use in future studies. - To collect information regarding food preparation and intake in these patients. Secondary - To make available to researchers medical data and biospecimens to enable them to develop better ways to screen people at risk for pancreatic conditions, including pancreatic cancer. - To investigate genes or substances that increase susceptibility of developing pancreatic conditions. - To find agents that may help prevent, treat, or cure these conditions. - To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers. OUTLINE: This is a multicenter study. Patients complete two 1-hour surveys assessing health, clinical and family history of pancreatic conditions including cancer, and food preparation and intake. Patients also complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health practices, and family history. A review of the patient's medical information is obtained from the medical record. Blood samples are collected for future research studies. Oral cells and stool samples may also be collected for future studies.

Who is eligible to participate?

DISEASE CHARACTERISTICS: - Diagnosis or suspicion of at least one of the following: - Pancreatic cancer - Pancreatic mass - Islet cell tumor - Intraductal papillary mucinous neoplasms (IPMN) - Hereditary pancreatitis PATIENT CHARACTERISTICS: - Able to understand and read English - Mentally competent and able to provide informed consent - Has not donated blood within the past 8 weeks PRIOR CONCURRENT THERAPY: - At least 7 days since prior blood transfusion - At least 7 days since prior surgery

Last updated:




IRB Number:

354-06 356-06